| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |